Trinity Biotech (TRIB) Cash & Equivalents Growth (5y) (2014 - 2025)
Trinity Biotech (TRIB) Cash & Equivalents Growth (5y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.50 Mn | 1.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.41% |
| Jun 30, 2025 | -19.80% |
| Dec 31, 2024 | -20.63% |
| Sep 30, 2024 | -35.32% |
| Jun 30, 2024 | -26.62% |
| Mar 31, 2024 | -27.80% |
| Dec 31, 2023 | -34.35% |
| Sep 30, 2023 | -16.80% |
| Jun 30, 2023 | -22.05% |
| Mar 31, 2023 | -42.02% |
| Dec 31, 2022 | -35.21% |
| Sep 30, 2022 | -16.15% |
| Jun 30, 2022 | -16.54% |
| Mar 31, 2022 | -32.19% |
| Dec 31, 2021 | -19.60% |
| Sep 30, 2021 | -20.17% |
| Jun 30, 2021 | -19.55% |
| Mar 31, 2021 | -19.73% |
| Dec 31, 2020 | -23.15% |
| Sep 30, 2020 | -28.19% |